[go: up one dir, main page]

ES2147780T3 - Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos. - Google Patents

Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.

Info

Publication number
ES2147780T3
ES2147780T3 ES94900557T ES94900557T ES2147780T3 ES 2147780 T3 ES2147780 T3 ES 2147780T3 ES 94900557 T ES94900557 T ES 94900557T ES 94900557 T ES94900557 T ES 94900557T ES 2147780 T3 ES2147780 T3 ES 2147780T3
Authority
ES
Spain
Prior art keywords
oak bark
bark extract
ions
procedure
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94900557T
Other languages
English (en)
Inventor
David N S Hon
R Thomas Stanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greystone Medical Group Inc
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Application granted granted Critical
Publication of ES2147780T3 publication Critical patent/ES2147780T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Laminated Bodies (AREA)
  • Road Paving Structures (AREA)

Abstract

LAS CONCENTRACIONES MAS ALTAS DE EXTRACTO DE CENIZA DE CORTEZA DE ROBLE, POR EJEMPLO, MAS GRANDES QUE EL 20% DE PESO, SON UTILES PARA EL TRATAMIENTO DE CANCERES DE PIEL. LAS CONCENTRACIONES DE EXTRACTO DE CORTEZA DE ROBLE POSEEN PROPIEDADES TERAPEUTICAS ADICIONALES NO POR ELLO RECONOCIDAS. POR EJEMPLO, LOS PREPARADOS QUE CONTIENEN EL 40-80% DE EXTRACTOS DE CORTEZA DE ROBLE SON UTILES EN EL TRATAMIENTO DE ULCERAS DE PIEL CANCEROSAS AGUDAS. EN ADICION, LAS MEZCLAS SINTETICAS QUE CONTIENEN IONES DE POTASIO, IONES DE ZINC, IONES DE CALCIO PROVEEN MUCHAS DE LAS MISMAS PROPIEDADES VENTAJOSAS DEL EXTRACTO DE CORTEZA DE ROBLE. LA INCLUSION DE IONES DE RUBIDIO Y AZUFRE ES TAMBIEN VENTAJOSA PARA ALGUNAS APLICACIONES.
ES94900557T 1992-11-06 1993-11-04 Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos. Expired - Lifetime ES2147780T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06

Publications (1)

Publication Number Publication Date
ES2147780T3 true ES2147780T3 (es) 2000-10-01

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94900557T Expired - Lifetime ES2147780T3 (es) 1992-11-06 1993-11-04 Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.

Country Status (21)

Country Link
US (1) US6149947A (es)
EP (1) EP0668769B1 (es)
JP (1) JP3640215B2 (es)
AT (1) ATE191850T1 (es)
AU (1) AU700019B2 (es)
BR (1) BR9307401A (es)
CA (1) CA2148795C (es)
CY (1) CY2231B1 (es)
CZ (1) CZ117395A3 (es)
DE (1) DE69328438T2 (es)
DK (1) DK0668769T3 (es)
ES (1) ES2147780T3 (es)
HU (1) HUT73791A (es)
MX (1) MX9306960A (es)
NO (1) NO951740L (es)
NZ (1) NZ258019A (es)
OA (1) OA10153A (es)
PL (1) PL308770A1 (es)
PT (1) PT668769E (es)
WO (1) WO1994011010A2 (es)
ZA (1) ZA938274B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
MXPA04005219A (es) * 2001-11-29 2005-06-20 Greystone Medical Group Inc Tratamiento de heridas y composiciones empleadas.
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
US20040023937A1 (en) * 2002-05-24 2004-02-05 Greystone Medical Group, Inc. Anti-cancer formulation
CA2511440A1 (en) * 2002-12-23 2004-07-15 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
CA2571314A1 (en) * 2004-06-22 2006-01-05 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
JP5038331B2 (ja) 2006-02-03 2012-10-03 ジェイアール ケム エルエルシー 銅と亜鉛の組成物を用いた老化防止治療
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
CA2700990C (en) 2007-03-15 2014-08-12 Om Kataria Uterine stimulant sticks
ES2891548T3 (es) * 2007-10-15 2022-01-28 Hs Pharmaceuticals Llc Composiciones que contienen silicato y métodos de tratamiento
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
US20160184354A1 (en) 2009-01-23 2016-06-30 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110200655A1 (en) * 2010-02-16 2011-08-18 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
US20140249462A1 (en) * 2011-07-20 2014-09-04 3M Innovatative Properties Company Dressing with ion-carrying composition
EP2736486B1 (en) * 2011-07-28 2019-03-06 3M Innovative Properties Company Wound-healing compositions and method of use
JP6697842B2 (ja) 2011-08-17 2020-05-27 スリーエム イノベイティブ プロパティズ カンパニー モノマーグラフト化繊維及びその使用
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2016123539A1 (en) 2015-01-29 2016-08-04 Wardell Mark R Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use
CA3131796C (en) * 2019-03-04 2023-10-03 Celloryx AG Chloride-inducible prokaryotic expression system
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.
WO2024196897A1 (en) * 2023-03-22 2024-09-26 Courtland Imel Novel methods for increasing healing speed of human and animal wounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US256847A (en) * 1882-04-25 Salve
US55911A (en) * 1866-06-26 Improved medical compound
US37901A (en) * 1863-03-17 Improved liniment
US202246A (en) * 1878-04-09 Improvement in medical compounds
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
EP0217975B1 (de) * 1985-10-08 1991-12-04 Psori-Med Ag Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
CY2231B1 (en) 2003-04-18
EP0668769B1 (en) 2000-04-19
WO1994011010A3 (en) 1994-09-15
JPH08503462A (ja) 1996-04-16
DE69328438T2 (de) 2001-01-04
DE69328438D1 (de) 2000-05-25
US6149947A (en) 2000-11-21
CA2148795A1 (en) 1994-05-26
AU5550094A (en) 1994-06-08
NO951740D0 (no) 1995-05-04
WO1994011010A2 (en) 1994-05-26
NO951740L (no) 1995-06-19
CZ117395A3 (en) 1995-11-15
ATE191850T1 (de) 2000-05-15
BR9307401A (pt) 1999-08-24
JP3640215B2 (ja) 2005-04-20
HU9501323D0 (en) 1996-05-28
CA2148795C (en) 2004-08-10
PL308770A1 (en) 1995-08-21
HUT73791A (en) 1996-09-30
OA10153A (en) 1996-12-18
ZA938274B (en) 1994-06-09
EP0668769A1 (en) 1995-08-30
MX9306960A (es) 1995-01-31
PT668769E (pt) 2000-10-31
DK0668769T3 (da) 2000-10-02
NZ258019A (en) 1998-12-23
AU700019B2 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
ES2147780T3 (es) Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
ATE190623T1 (de) Verwendung von steroiden zur inhibierung von angiogenesis
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
MX9200675A (es) Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral.
ES2033434T3 (es) Composicion cosmetica.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
NO820429L (no) Tetrahydronaftalin- og indanforbindelser
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ES2058191T3 (es) Acidos 2-fenil-4-quinolincarboxilicos substituidos.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE59908268D1 (de) Khellin-zubereitung und deren verwendung zur topischen therapie
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
ATE128354T1 (de) Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.
GB8428552D0 (en) Organic compounds
ES2106858T3 (es) Nuevos derivados de la citarabina, su procedimiento de preparacion y su uso contra enfermedades cancerosas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 668769

Country of ref document: ES